Cardiff Oncology Inc. buy quelbe60
Start price
20.02.22
/
50%
€2.52
Target price
20.02.23
-
Performance (%)
-16.67%
End price
05.03.22
€2.10
Summary
This prediction ended on 05.03.22 with a price of €2.10. The price of Cardiff Oncology Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.67%. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -3.650% | -3.650% | -60.405% | -54.810% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% | 63.642% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% | 88.123% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% | 83.527% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% | 68.755% |
Comments by quelbe60 for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.